Drawing for POSLUMA XACT

USPTO serial 79462708

POSLUMA XACT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with POSLUMA XACT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; positron emission tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in positron emission tomography (PET) imaging for laboratory and research use; reagents for use in positron emission tomography (PET) imaging for laboratory and research use; diagnostic scanning agents for in-vivo use for medical research use; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use.ACTIVE—
005Diagnostic preparations for medical purposes; medical preparations in the nature of contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use in medical imaging; positron emission tomography (PET) tracing chemicals for medical use; PET tracing chemicals and reagents prepared for ingestion or injection into humans and animals for medical use; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging, namely, contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use with imaging medical equipment; contrast agents for use in medical imaging and molecular imaging; amino acids for use in medical imaging.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 13, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 13, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance